TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts

Detalles Bibliográficos
Autores principales: Yamrozik, June A, Doyle, Mark, Rathi, Vikas K, Vido, Diane A, Williams, Ronald B, Rayarao, Geetha, Biederman, Robert WW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860797/
http://dx.doi.org/10.1186/1532-429X-11-S1-P189
_version_ 1783646956079284224
author Yamrozik, June A
Doyle, Mark
Rathi, Vikas K
Vido, Diane A
Williams, Ronald B
Rayarao, Geetha
Biederman, Robert WW
author_facet Yamrozik, June A
Doyle, Mark
Rathi, Vikas K
Vido, Diane A
Williams, Ronald B
Rayarao, Geetha
Biederman, Robert WW
author_sort Yamrozik, June A
collection PubMed
description
format Online
Article
Text
id pubmed-7860797
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78607972021-03-09 TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts Yamrozik, June A Doyle, Mark Rathi, Vikas K Vido, Diane A Williams, Ronald B Rayarao, Geetha Biederman, Robert WW J Cardiovasc Magn Reson Poster Presentation BioMed Central 2009-01-28 /pmc/articles/PMC7860797/ http://dx.doi.org/10.1186/1532-429X-11-S1-P189 Text en © Yamrozik et al; licensee BioMed Central Ltd. 2009, This article is published under license to BioMed Central Ltd. Open AccessThis article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Yamrozik, June A
Doyle, Mark
Rathi, Vikas K
Vido, Diane A
Williams, Ronald B
Rayarao, Geetha
Biederman, Robert WW
TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
title TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
title_full TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
title_fullStr TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
title_full_unstemmed TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
title_short TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
title_sort ti nulling and contrast conditions with a 0.15 mmol/kg dosage of multihance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860797/
http://dx.doi.org/10.1186/1532-429X-11-S1-P189
work_keys_str_mv AT yamrozikjunea tinullingandcontrastconditionswitha015mmolkgdosageofmultihanceascomparedtothestandard02mmolkggadoliniumdosageinpatientswithmyocardialinfarcts
AT doylemark tinullingandcontrastconditionswitha015mmolkgdosageofmultihanceascomparedtothestandard02mmolkggadoliniumdosageinpatientswithmyocardialinfarcts
AT rathivikask tinullingandcontrastconditionswitha015mmolkgdosageofmultihanceascomparedtothestandard02mmolkggadoliniumdosageinpatientswithmyocardialinfarcts
AT vidodianea tinullingandcontrastconditionswitha015mmolkgdosageofmultihanceascomparedtothestandard02mmolkggadoliniumdosageinpatientswithmyocardialinfarcts
AT williamsronaldb tinullingandcontrastconditionswitha015mmolkgdosageofmultihanceascomparedtothestandard02mmolkggadoliniumdosageinpatientswithmyocardialinfarcts
AT rayaraogeetha tinullingandcontrastconditionswitha015mmolkgdosageofmultihanceascomparedtothestandard02mmolkggadoliniumdosageinpatientswithmyocardialinfarcts
AT biedermanrobertww tinullingandcontrastconditionswitha015mmolkgdosageofmultihanceascomparedtothestandard02mmolkggadoliniumdosageinpatientswithmyocardialinfarcts

Ejemplares similares